Protagonist Therapeutics, Inc (PTGX) › Capital ExpendituresProtagonist Therapeutics, Inc (PTGX) — Capital ExpendituresAnnual figures by period end, from SEC filings.2014-12-31: $299.0K2015-12-31: $399.0K2016-12-31: $347.0K2017-12-31: $666.0K2018-12-31: $486.0K2019-12-31: $967.0K2020-12-31: $471.0K2021-12-31: $1.10M2022-12-31: $795.0K2023-12-31: $609.0K2024-12-31: $1.35M2025-12-31: $1.59M$1.59M2014-12-31Capital Expenditures (USD)2025-12-31Period endedCapital ExpendituresChange YoYSource filing2025-12-31$1.59M+17.3%2026-02-25From 2025-01-012024-12-31$1.35M+122.5%2026-02-25From 2024-01-012023-12-31$609.0K-23.4%2026-02-25From 2023-01-012022-12-31$795.0K-27.8%2025-02-21From 2022-01-012021-12-31$1.10M+133.8%2024-02-27From 2021-01-012020-12-31$471.0K-51.3%2023-03-15From 2020-01-012019-12-31$967.0K+99.0%2022-02-28From 2019-01-012018-12-31$486.0K-27.0%2021-03-10From 2018-01-012017-12-31$666.0K+91.9%2020-03-10From 2017-01-012016-12-31$347.0K-13.0%2019-03-12From 2016-01-012015-12-31$399.0K+33.4%2018-03-07From 2015-01-012014-12-31$299.0K—2017-03-07From 2014-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)